Clinical Trial Update: Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating liposomal SN-38 for small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Liposomal SN-38 (liposomal SN-38)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 2 | Status: WITHDRAWN